AzTrials
AzTrials

Breastfeeding EducationLACT-EDNCT06863597

Breastfeeding Advices on OTC Medicines With the Internet: What is the Best Medium

A study testing Video content, Written content and Podcast content in people with Breastfeeding Education and Lactating Mother, run by Semmelweis University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Pharmacotherapy for lactating women in Hungary presents a unique challenge. While certain medications may pose risks to the infant or reduce breast milk production, the unnecessary avoidance of treatment can also be harmful. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Video content, Written content and Podcast content
Could I receive a placebo?
No, everyone receives an active treatment
How many people
380 participants
Where
No sites listed yet
Study dates
Aug 2025to Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Target population is adult (>18 years), 3rd trimester pregnant women; and breastfeeding women after childbirth (max. 7 days postpartum; 24:00), who intend to breastfeed.
  • Participants have to have internet access with no regard to the type of internet connection.

Who cannot join

  • A mother will not breastfeed, either because they cannot or do not want it.
  • Anyone who do not want to participate in the study.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Kleiner Dénes, PhD contact

+36206164590

kleiner.denes@semmelweis.hu

Dezső Csupor, DSc contact

csupor.dezso@gmail.com

About this study

Official title: A Multi-Center Randomized, Parallel-Group Study to Compare Knowledge Translation Between Different Media in Pregnant and Lactating Women

Pharmacotherapy for lactating women in Hungary presents a unique challenge. While certain medications may pose risks to the infant or reduce breast milk production, the unnecessary avoidance of treatment can also be harmful. Despite this, no dedicated Hungarian website currently provides guidance on the safe use of over-the-counter (OTC) medications for breastfeeding mothers.

To address this gap, the aim is to develop a website that not only meets clinical standards but also presents essential information in a clear, accessible format that helps mothers understand and retain key details by choosing the best medium.

Our main question is: What is the most effective way to educate lactating women about OTC medication use through an online platform?

Being tested
Video content, Written content, Podcast content, Illustration (information leaflet) content
Medical subject headings
Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video contentOther

    Video content produced by media professionals using expert opinions.

  • Written contentOther

    Written content produced by healthcare professionals with experience in health education.

  • Podcast contentOther

    Podcast content created by media experts based on expert opinions.

  • Illustration (information leaflet) contentOther

    Illustration-based content created by media experts using expert opinions.

Study groups in NCT06863597
Study groupRoleWhat they receive
Video contentExperimentalParticipating mothers watch a video on a specific topic.
Receives: Other: Video content
Written contentExperimentalParticipating mothers read a text about a specific topic.
Receives: Other: Written content
Podcast contentExperimentalParticipating mothers listen to a podcast on a specific topic.
Receives: Other: Podcast content
Illustration (information leaflet) contentExperimentalParticipating mothers view an illustration on a specific topic.
Receives: Other: Illustration (information leaflet) content

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knowledge translation

    Knowledge translation will be measured by the difference in test scores before and after the intervention. The tests will be developed through common consensus. Since topic-specific tests will be created individually for each topic, only their utility will be assessed in a pilot study, and validation is not planned.

    Measured: From enrollment in the first week, followed by an assessment after 6 months.

Secondary outcomes (1)
  1. User-satisfaction

    Questionnaire about user-satisfaction.

    Measured: From enrollment in the first week, followed by an assessment after 6 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2025
  2. Study startAug 2025 (estimated)
  3. Primary completionApr 2027 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
380 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06863597
Sponsor's protocol ID
9/2024
Other IDs
BM/26617-3/2024
Acronym
LACT-ED
Status last verified
Feb 2025
First submitted
3 Mar 2025
Last updated
11 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Video content, Written content and Podcast content in people with Breastfeeding Education and Lactating Mother, run by Semmelweis University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kleiner Dénes, PhD (+36206164590, kleiner.denes@semmelweis.hu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knowledge translation (time frame: From enrollment in the first week, followed by an assessment after 6 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in